It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.

Jack Phillips Biography and Net Worth

CEO of Accelerate Diagnostics

Jack Phillips has served as President and Chief Executive Officer of Accelerate Diagnostics since February 2020. Mr. Phillips joined the company in September of 2019 as Chief Operating Officer. From 2010 to 2019, Mr. Phillips served as President and CEO of Roche Diagnostics North America, the world leader in in-vitro diagnostics. During this time, Jack also served as a member of the Roche Global Diagnostics Leadership Team. Before joining Roche Diagnostics, Mr. Phillips served as Senior Vice President of Commercial Operations, North America at Ventana Medical Systems, a member of the Roche Group, and the world leader in tissue-based cancer diagnostics. Mr. Phillips has also served in commercial leadership roles at Bayer Diagnostics and Motorola. He serves as a member of the AdvaMedDx Board of Directors in Washington, D.C. and previously served as Chairman of the Board for Central Indiana Corporate Partnership in Indianapolis, IN.

What is Jack Phillips' net worth?: The estimated net worth of Jack Phillips is at least $289,995.82 as of April 17th, 2024. Mr. Phillips owns 162,919 shares of Accelerate Diagnostics stock worth more than $289,996 as of November 20th. This net worth approximation does not reflect any other investments that Mr. Phillips may own. Additionally, Mr. Phillips receives an annual salary of $595,000.00 as CEO at Accelerate Diagnostics. Learn More about Jack Phillips' net worth.
How old is Jack Phillips?: Mr. Phillips is currently 58 years old. There are 2 older executives and no younger executives at Accelerate Diagnostics. Learn More on Jack Phillips' age.
What is Jack Phillips' salary?: As the CEO of Accelerate Diagnostics, Inc., Mr. Phillips earns $595,000.00 per year. Learn More on Jack Phillips' salary.
How do I contact Jack Phillips?: The corporate mailing address for Mr. Phillips and other Accelerate Diagnostics executives is 3950 South Country Club Suite 470, Tucson AZ, 85714. Accelerate Diagnostics can also be reached via phone at (520) 365-3100 and via email at [email protected]. Learn More on Jack Phillips' contact information.
Has Jack Phillips been buying or selling shares of Accelerate Diagnostics?: Jack Phillips has not been actively trading shares of Accelerate Diagnostics during the past quarter. Most recently, Jack Phillips sold 26,735 shares of the business's stock in a transaction on Wednesday, April 17th. The shares were sold at an average price of $0.78, for a transaction totalling $20,853.30. Following the completion of the sale, the chief executive officer now directly owns 162,919 shares of the company's stock, valued at $127,076.82. Learn More on Jack Phillips' trading history.
Who are Accelerate Diagnostics' active insiders?: Accelerate Diagnostics' insider roster includes Hany Massarany (Director), Jack Phillips (CEO), Ron Price (Insider), Steven Reichling (CFO), and Jack Schuler (Director). Learn More on Accelerate Diagnostics' active insiders.
Are insiders buying or selling shares of Accelerate Diagnostics?: During the last twelve months, insiders at the medical research company sold shares 11 times. They sold a total of 99,466 shares worth more than $87,222.72. The most recent insider tranaction occured on May, 20th when CTO Larry Michael Mertz sold 361 shares worth more than $317.68. Insiders at Accelerate Diagnostics own 43.6% of the company. Learn More about insider trades at Accelerate Diagnostics.
Information on this page was last updated on 5/20/2024.

Jack Phillips Insider Trading History at Accelerate Diagnostics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/17/2024	Sell	26,735	$0.78	$20,853.30	162,919
4/12/2024	Sell	26,545	$0.86	$22,828.70	129,726
4/4/2024	Sell	15,887	$0.88	$13,980.56	96,343
2/1/2024	Sell	494	$1.30	$642.20	76,707
12/13/2023	Sell	739	$4.39	$3,244.21	59,535
10/13/2023	Sell	734	$5.83	$4,279.22	57,576
9/13/2023	Sell	733	$6.53	$4,786.49	56,589
8/14/2023	Sell	751	$6.80	$5,106.80	55,600
7/13/2023	Sell	729	$6.90	$5,030.10	54,629
6/22/2023	Sell	2,726	$7.10	$19,354.60	53,636
6/13/2023	Sell	839	$9.00	$7,551.00	50,146
5/15/2023	Sell	794	$6.90	$5,478.60	49,263
4/13/2023	Sell	744	$6.50	$4,836.00	48,336
3/13/2023	Sell	745	$4.90	$3,650.50	47,358
3/8/2023	Sell	15,563	$4.70	$73,146.10	46,382
2/13/2023	Sell	860	$6.00	$5,160.00	26,945
1/13/2023	Sell	840	$6.90	$5,796.00	25,084
6/22/2022	Sell	2,819	$9.10	$25,652.90	24,203
4/28/2022	Sell	8,370	$9.80	$82,026.00	20,807
2/1/2022	Sell	365	$32.60	$11,899.00
6/22/2021	Sell	2,347	$79.40	$186,351.80	13,617
5/13/2021	Sell	2,506	$67.60	$169,405.60	9,908

Jack Phillips Buying and Selling Activity at Accelerate Diagnostics

Accelerate Diagnostics Company Overview

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.

Today's Range

Now: $1.78

$1.76

$1.78

50 Day Range

MA: $1.78

$1.47

$2.02

2 Week Range

Now: $1.78

$0.73

$5.23

Volume

1,547 shs

Average Volume

81,756 shs

Market Capitalization

$44.57 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.59

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

From Colonial Metals | Ad

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

Claim your FREE 2024 Gold Guide

Jack Phillips Biography and Net Worth

What is Jack Phillips' net worth?

How old is Jack Phillips?

What is Jack Phillips' salary?

How do I contact Jack Phillips?

Has Jack Phillips been buying or selling shares of Accelerate Diagnostics?

Who are Accelerate Diagnostics' active insiders?

Are insiders buying or selling shares of Accelerate Diagnostics?